Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease

Area of Science:

• Neuroscience
• Pharmacology
• Pathology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder marked by synaptic dysfunction, brain atrophy, amyloid plaques, and neurofibrillary tangles.
• AD presents with cognitive, functional, and behavioral impairments, driven by complex, interacting pathophysiological pathways.
• Current AD treatments primarily focus on symptom alleviation, often with limited efficacy due to the disease's multifactorial nature.

Purpose of the Study:

• To review the pathogenesis of Alzheimer's disease.
• To provide an overview of current drug therapies for AD.
• To discuss the rationale and examples of multi-target therapeutic strategies for AD.

Main Methods:

• Literature review of Alzheimer's disease pathogenesis.
• Analysis of current pharmacological treatments for AD.
• Exploration of multi-target drug strategies and their mechanisms.

Main Results:

• Single-target treatments for AD often fall short due to the disease's complexity.
• Multi-target strategies offer a promising approach by addressing several pathological pathways simultaneously.
• Various multi-target drugs demonstrate potential pharmacological actions against AD.

Conclusions:

• The multifactorial nature of Alzheimer's disease necessitates advanced therapeutic strategies.
• Multi-target approaches represent a significant advancement in AD drug development.
• Further research into multi-target drugs is crucial for effective Alzheimer's disease management.